Search Videos and More
Video
Narjust Florez, MD Discusses Young Lung Cancer
Lung cancer rates in younger adults are rising. Dana-Farber's Narjust Florez, MD discusses research showing that young patients with lung cancer face ample financial toxicity and issues impacting physical, emotional, and functional well-being.
Video
Narjust Florez, MD Discusses International Medical Graduate Challenges
1 out of 4 doctors in the United States graduated from international medical schools, yet according to a study presented at ASCO24, these doctors remain victims of discrimination at frequent rates.
Video
Kenneth Kehl, MD, MPH Reviews Artificial Intelligence and Genomic Data
Using artificial intelligence to link genomic data to clinical outcomes in cancer care across institutions without compromising protected health information is challenging.
Video
Richard Leiter, MD, MA Featured in ASCO Voices
Palliative care physician Richard Leiter, MD, MA, recounts his support of a young patient with end-of-life care and the complexities of communicating with his family.
Video
Andrew Hantel, MD Reviews Cancer Care and Greenhouse Gases
Telehealth can significantly reduce greenhouse gas emissions from cancer care, with research showing decentralized cancer care and telemedicine can cut emissions 33% compared to traditional in-person visits.
Video
Toni Choueiri, MD Discusses Kidney Cancer JAVELIN 101
Kidney cancer research at ASCO24: Final analysis in JAVELIN Renal 101 trial confirms the efficacy and manageable safety profile of avelumab plus axitinib versus sunitinib in patients with advanced kidney cancer. Dana-Farber's Toni Choueiri, MD, explains more.
Video
Kimia Sorouri, MD, MPH Discusses Fertility and Breast Cancer
Study shows most women attempting to conceive after breast cancer treatment can do so and give birth. Dana-Farber's Kimia Sorouri, MD, MPH, discusses the first prospective study with more than 10 years of follow-up that also accounts for conception attempts.
Video
Toni Choueiri, MD Provides Kidney Cancer CLEAR Trial biomarker analysis
Biomarker analysis in the phase 3 CLEAR trial shows biomarkers don't impact the superiority of lenvatinib plus pembrolizumab versus sunitinib as a first-line therapy in patients diagnosed with advanced kidney cancer.
News
Study Identifies Novel Target for Pediatric Neuroblastoma
Researchers at Dana-Farber Cancer Institute have identified a protein complex that is required for the growth of a high-risk form of childhood brain cancer called MYCN-amplified neuroblastoma.
News
Research Provides New Insights Into ‘Infernal’ Mode of Cell Death
A group of scientists at Dana-Farber have trained their attention on an ancient family of proteins, called gasdermins, that punch holes, or pores, in the cell membrane during pyroptosis.
News
Telehealth Can Significantly Reduce Greenhouse Gas Emissions Associated with Cancer Care, Study Finds
Telemedicine visits for cancer care may not only be more convenient and easier to schedule than in-person appointments, they're also better for the planet, new research by Dana-Farber Cancer Institute scientists shows.
Symposium
AACR 2024 Highlights
Review presentations and information shared by Dana-Farber physician-scientists at the 2024 American Association of Cancer Research (AACR) Annual Meeting held April 5-10, San Diego, CA.